Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE	Hemic and Lymphatic Diseases, Hodgkins lymphoma, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, non-Hodgkin lymphoma	Recruiting	Phase 1	2026-03-02		NCT01555892

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Baylor College of Medicine	267
Center for Cell and Gene Therapy, Baylor College of Medicine	40
Harris County Hospital District	2
National Cancer Institute (NCI)	3015
National Institutes of Health (NIH)	667
The Methodist Hospital Research Institute	124

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Harris Health System (includes ben Taub General Hospital and Smith)	Houston	United States	1
Houston Methodist Hospital	Houston	United States	260
Texas Children's Hospital	Houston	United States	187